P2.07-061 Nivolumab for Patients with Non-Small Cell Lung Carcinoma in Patients with Progression to One or More Lines of Chemotherapy in Mexican Population

J. Rodriguez-Cid; D. Bonilla-Molina; L. Martínez-Barreda; J. Díaz-Rico; P. Arellanes-Herrera; E. Del Olmo Gil; J.C. Chagoya-Bello; J.A. Alatorre Alexander

首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >P2.07-061 Nivolumab for Patients with Non-Small Cell Lung Carcinoma in Patients with Progression to One or More Lines of Chemotherapy in Mexican Population

【24h】

P2.07-061 Nivolumab for Patients with Non-Small Cell Lung Carcinoma in Patients with Progression to One or More Lines of Chemotherapy in Mexican Population

机译：P2.07-061 Nivolumab用于患者的非小细胞肺癌患者进展到墨西哥人群的一种或多种化疗患者

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第11期|共1页
作者
J. Rodriguez-Cid; D. Bonilla-Molina; L. Martínez-Barreda; J. Díaz-Rico; P. Arellanes-Herrera; E. Del Olmo Gil; J.C. Chagoya-Bello; J.A. Alatorre Alexander;
展开▼
作者单位

Centro de Oncología Toracica Instituto Nacional de Enfermedades Respiratorias;

Centro de Oncología Toracica Instituto Nacional de Enfermedades Respiratorias;

Centro de Oncología Toracica Instituto Nacional de Enfermedades Respiratorias;

Centro de Oncología Toracica Instituto Nacional de Enfermedades Respiratorias;

Centro de Oncología Toracica Instituto Nacional de Enfermedades Respiratorias;

Centro de Oncología Toracica Instituto Nacional de Enfermedades Respiratorias;

Centro de Oncología Toracica Instituto Nacional de Enfermedades Respiratorias;

Centro de Oncología Toracica Instituto Nacional de Enfermedades Respiratorias;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. P2.07-061 Nivolumab for Patients with Non-Small Cell Lung Carcinoma in Patients with Progression to One or More Lines of Chemotherapy in Mexican Population [J] . J. Rodriguez-Cid, D. Bonilla-Molina, L. Martínez-Barreda, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第11期

机译：P2.07-061 Nivolumab用于患者的非小细胞肺癌患者进展到墨西哥人群的一种或多种化疗患者
2. P3.02c-045 Experience with Nivolumab in Compassionate Use in Non-Small Lung Carcinoma Patients Who Have Progressed to One or More Prior Lines of Chemotherapy [J] . Paula Ribera Fernandez, Maria Marin Alcala, Juan Carlos Pardo Ruiz, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：P3.02C-045患有Nivolumab的体验在富含小小的肺癌患者的富有同情心，他们已经进入一种或多种前进的化疗
3. CheckMate-227 shows superior progression-free Survival for Nivolumab in combination with Ipilimumab versus Chemotherapy in the First-line Treatment of non-small cell Lung Cancer Patients with high Tumor Mutational Burden [J] . Oncology research and treatment. . 2018,第4期

机译：checkmate-227显示了Nivolumab的优异进展生存期与Ipilimalab与化疗组合，在肿瘤突变负担的非小细胞肺癌患者的一线治疗中
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Predictors of changes in health-related quality of life during chemotherapy in an advanced non-small cell lung cancer patient population [D] . Shallwani, Shirin Mehdi 2010

机译：非小细胞肺癌晚期患者化疗期间健康相关生活质量变化的预测因子
6. An open label randomized Phase III trial of nivolumab or nivolumab plus ipilimumab vs platinum doublet chemotherapy (PT-DC) in patients with chemotherapy-naïve stage IV or recurrent non-small cell lung cancer (NSCLC) (CheckMate 227) [O] . Matthew Hellmann, Suresh Ramalingam, Martin Reck, 2015

机译：一项针对nvolumab或nivolumab联合ipilimumab与铂类双重化疗（PT-DC）的初治IV期或复发性非小细胞肺癌（NSCLC）患者的开放标签随机III期临床试验（CheckMate 227）
7. An open label randomized Phase III trial of nivolumab or nivolumab plus ipilimumab vs platinum doublet chemotherapy (PT-DC) in patients with chemotherapy-naïve stage IV or recurrent non-small cell lung cancer (NSCLC) (CheckMate 227) [O] . Matthew Hellmann, Suresh Ramalingam, Martin Reck, 2015

机译：一项针对nvolumab或nivolumab联合ipilimumab与铂类双重化疗（PT-DC）的初治IV期或复发性非小细胞肺癌（NSCLC）患者的开放标签随机III期临床试验（CheckMate 227）

P2.07-061 Nivolumab for Patients with Non-Small Cell Lung Carcinoma in Patients with Progression to One or More Lines of Chemotherapy in Mexican Population

著录项

相似文献

相关主题

期刊订阅